Statistics from Altmetric.com
Randomised controlled trial.
Single blind (assessors blinded).
Follow up period:
Twelve weeks (treatment period only).
Outpatient setting in Brazil; March 2002 to December 2003.
Fifty six adults (mean 38.5 years) with diagnosed with DSM-IV obsessive-compulsive disorder (OCD; Mini-International Neuropsychiatric Interview – Brazilian version), and a Yale-Brown Obsessive Compulsive Scale (YBOCS) score of ⩾16. Main exclusion criteria: moderate to severe major depression, Beck Depression Inventory score >16, bipolar disorder, severe personality disorder, psychotic disorder, substance related disorder in the previous six months, Tourette’s syndrome, or organic brain disease.
Group cognitive behavioural therapy (CBT; weekly two-hour group session) or sertraline (50 mg/day in the …
For correspondence: Aristides V Codioli, MD, PhD, Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2350, Room 400N, Porto Alegre, RS, Brazil 90035-903;
Sources of funding: Coordenacao de Aperfeicoamento de Ensino Superior (CAPES), Fundacao de Incentivo a Pesquisa e a Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre, Brazil. Sertraline was provided by Pfizer Inc, Sao Paulo, Brazil.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.